Cargando…

Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?

Detalles Bibliográficos
Autores principales: Cerqueira, João J, Compston, D Alastair S, Geraldes, Ruth, Rosa, Mario M, Schmierer, Klaus, Thompson, Alan, Tinelli, Michela, Palace, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204938/
https://www.ncbi.nlm.nih.gov/pubmed/29618493
http://dx.doi.org/10.1136/jnnp-2017-317509
_version_ 1783366114363834368
author Cerqueira, João J
Compston, D Alastair S
Geraldes, Ruth
Rosa, Mario M
Schmierer, Klaus
Thompson, Alan
Tinelli, Michela
Palace, Jacqueline
author_facet Cerqueira, João J
Compston, D Alastair S
Geraldes, Ruth
Rosa, Mario M
Schmierer, Klaus
Thompson, Alan
Tinelli, Michela
Palace, Jacqueline
author_sort Cerqueira, João J
collection PubMed
description
format Online
Article
Text
id pubmed-6204938
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-62049382018-10-30 Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? Cerqueira, João J Compston, D Alastair S Geraldes, Ruth Rosa, Mario M Schmierer, Klaus Thompson, Alan Tinelli, Michela Palace, Jacqueline J Neurol Neurosurg Psychiatry Multiple Sclerosis BMJ Publishing Group 2018-08 2018-04-04 /pmc/articles/PMC6204938/ /pubmed/29618493 http://dx.doi.org/10.1136/jnnp-2017-317509 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Multiple Sclerosis
Cerqueira, João J
Compston, D Alastair S
Geraldes, Ruth
Rosa, Mario M
Schmierer, Klaus
Thompson, Alan
Tinelli, Michela
Palace, Jacqueline
Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
title Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
title_full Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
title_fullStr Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
title_full_unstemmed Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
title_short Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
title_sort time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
topic Multiple Sclerosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204938/
https://www.ncbi.nlm.nih.gov/pubmed/29618493
http://dx.doi.org/10.1136/jnnp-2017-317509
work_keys_str_mv AT cerqueirajoaoj timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis
AT compstondalastairs timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis
AT geraldesruth timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis
AT rosamariom timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis
AT schmiererklaus timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis
AT thompsonalan timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis
AT tinellimichela timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis
AT palacejacqueline timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis